Konstantin Gundilovich

Senior Scientist, Analytical Development at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Konstantin Gundilovich's Colleagues at Alnylam Pharmaceuticals
Layllah Duarte

Talent Acquisition Coordinator - Commercial

Contact Layllah Duarte

Bhaumik Pandya

Principal Scientist, Medicinal Chemistry

Contact Bhaumik Pandya

Ran Ye

Senior Scientist, Bioanalytical Outsourcing

Contact Ran Ye

Lisa Martina

Business Account Executive

Contact Lisa Martina

Shawn Nordquist

Business Account Executive

Contact Shawn Nordquist

Liam Weaver

Global Planning Associate

Contact Liam Weaver

View All Konstantin Gundilovich's Colleagues
Konstantin Gundilovich's Contact Details
HQ
(617) 551-8200
Location
Company
Alnylam Pharmaceuticals
Konstantin Gundilovich's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Konstantin Gundilovich
Konstantin Gundilovich currently works for Alnylam Pharmaceuticals.
Konstantin Gundilovich's role at Alnylam Pharmaceuticals is Senior Scientist, Analytical Development.
Konstantin Gundilovich's email address is ***@alnylam.com. To view Konstantin Gundilovich's full email address, please signup to ConnectPlex.
Konstantin Gundilovich works in the SaaS industry.
Konstantin Gundilovich's colleagues at Alnylam Pharmaceuticals are Layllah Duarte, Bhaumik Pandya, Ran Ye, Lisa Martina, Carissa Willis, Shawn Nordquist, Liam Weaver and others.
Konstantin Gundilovich's phone number is (617) 551-8200
See more information about Konstantin Gundilovich